Throughout evolution, plants have continuously adapted to survive in changing environments. Apart from complex structural ...

Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...

Q4 2024 Earnings Call Transcript March 26, 2025 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $ ...

French precision fermentation startup Bon Vivant has rebranded to Verley and rolled out a range of functional animal-free ...

China's government officials have called for a boost to the biotech capacity and the introduction of a novel food framework ...

This infographic highlights the key advantages of CHO cells and the technologies that are pushing the boundaries of cell ...

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024Up to $7.5 million in grants awarded from CEPI and Gates Foundation intended to acceler ...

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024Up to $7.5 ...

The project was led by Dr. Xiaoli Zhang, the Company’s research manager, whose team continues to push the boundaries of genetic engineering for spider silk production.

Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® ...

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.